Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Alternext  >  Median Techno    ALMDT   FR0011049824

Delayed Quote. Delayed  - 09/26 09:00:05 am
8.98 EUR   --.--%
08/08 MEDIAN TECHNOLO : Disclosure of Total Number of Voting Rights and Nu..
07/12 MEDIAN TECHNOLO : Strengthens Its Medical Expertise Department by Ap..
07/07 MEDIAN TECHNOLO : Financial Communications Schedule for the Second H..
SummaryQuotesChartsNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector news 

MEDIANTECHNOLOGIES : MEDIAN Technologies Names Ciaran Cooper as Head of Business Development, Clinical Trials Imaging, North America

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/04/2012 | 07:35am CEST

Ciaran Cooper will be responsible for developing the company's US market in oncology clinical trials and will assist in managing the relationship between MEDIAN and Quintiles

Regulatory News:

MEDIAN Technologies (Paris:ALMDT), a leading medical imaging software solutions developer, and a service provider for image interpretation and management in oncology clinical trials, announced today that it has named Ciaran Cooper as Head of Business Development, Clinical Trials Imaging, North America. Ciaran Cooper will be responsible for developing the company's US market in oncology clinical trials and will assist in managing the strategic relationship between MEDIAN Technologies and Quintiles.

Ciaran Cooper, an entrepreneur and early innovator in the clinical trials imaging services industry, brings over 20 years' experience in medical imaging with an emphasis in business development, strategic planning, and team management. Along with colleagues from the University of Chicago, Ciaran Cooper co-founded MIICRO, Inc. in 1995, the first imaging CRO specialized in early phase translational imaging with FDG PET. He was CEO of MIICRO until 2003. Since then, Ciaran Cooper has worked for several imaging services and technology companies as a senior manager in business development and thus brings with him a vast knowledge of various business models, therapeutic areas, and growth strategies.

"I'm very excited to join MEDIAN at this time in their development," said Ciaran Cooper. "MEDIAN's LMS solution provides a quantum leap forward in how medical imaging can be applied to oncology clinical trials. I look forward to carrying our message to market."

"We're thrilled to welcome Ciaran to our team," said Jerome Windsor, VP Business Development at MEDIAN Technologies. "Ciaran has a unique perspective on the industry and he brings an entrepreneurial spirit and enthusiasm that will fit well with our growing company."

About MEDIAN Technologies: MEDIAN Technologies provides advanced imaging solutions for diagnosing and monitoring cancer patients in clinical trials and in routine clinical practice. MEDIAN collaborates with institutes at the cutting edge of medical imaging, including the French National Institute for Computer Science and Control (INRIA), the University of Chicago, and the Swiss Federal Institute of Technology in Lausanne, Switzerland (EPFL). MEDIAN is present in the market through direct and indirect sales of its LMS solutions and through alliances with specialist cancer centers in Europe and the USA. MEDIAN has a strategic partnership with Quintiles, to offer integrated imaging services for clinical trials to customers worldwide.

Based in Sophia Antipolis, France, MEDIAN was founded in 2002 by Fredrik Brag (Current CEO), Gérard Milhiet, and Arnaud Butzbach. The company has a staff of 40, over half of whom work in R&D, and has a US-based subsidiary.

For more information on MEDIAN, please visit: www.mediantechnologies.com

MEDIAN Technologies
Fredrik Brag, CEO
+33 4 92 90 65 82
fredrik.brag@mediantechnologies.com
or
Press - ALIZE RP
Caroline Carmagnol
+ 33 6 64 18 99 59 // + 33 1 42 68 86 43
caroline@alizerp.com
Anne-Sophie Cosquéric
+ 33 1 42 68 86 41
Anne-sophie@alizerp.com


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MEDIAN TECHNO
08/08 MEDIAN TECHNOLOGIES : Disclosure of Total Number of Voting Rights and Number of ..
07/12 MEDIAN TECHNOLOGIES : Strengthens Its Medical Expertise Department by Appointing..
07/07 MEDIAN TECHNOLOGIES : Financial Communications Schedule for the Second Half of 2..
07/06 MEDIAN TECHNO : Half-Year MEDIAN Technologies Liquidity Contract Statement Contr..
06/28 MEDIAN TECHNOLOGIES : and START Expand Relationship to Three New Centers in Gran..
06/23 MEDIAN TECHNOLOGIES : and Microsoft Sign Collaborative Agreement to Develop New ..
06/22 MEDIAN TECHNO : Technologies and Microsoft Sign Collaborative Agreement to Devel..
05/23 MEDIAN TECHNO : Technologies Concludes a New Collaboration Agreement with the Wo..
05/12 MEDIAN TECHNOLOGIES : Boosts Its Presence in the US and Announces Major Expansio..
05/03 MEDIAN TECHNOLOGIES : Order Intake Totaling €3.32M for Q1, 2016
More news
Sector news : Software - NEC
09/26DJAdobe Makes Microsoft's Azure 'Preferred' Service
09/26DJAdobe Makes Microsoft's Azure 'Preferred' Service
09/26DJApple Goes Without a Lobby Into European Fray
09/23DJLINKEDIN : Unveils New Technology -- WSJ
09/22DJLINKEDIN : Rolls Out New Technology
More sector news : Software - NEC
Advertisement
Chart MEDIAN TECHNO
Duration : Period :
Median Techno Technical Analysis Chart | ALMDT | FR0011049824 | 4-Traders
Full-screen chart
Managers
NameTitle
Fredrik Bjjorn Brag Chairman, CEO & Head-Investor Relations
Arnaud Butzbach Chief Technology Officer & VP-Operations
Bernard Reymann Chief Financial Officer
Souhil Zaïm Chief Medical Officer
Gerard Milhiet Director & Executive Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MEDIAN TECHNO-25.17%101
MICROSOFT CORPORATION2.56%447 524
HEXAGON AB18.04%15 011
RED HAT INC-4.91%14 330
CITRIX SYSTEMS, INC.11.78%13 223
SYNOPSYS, INC.29.75%8 987
More Results